Sarah Cannon Outcomes Registry

December 1, 2023 updated by: SCRI Development Innovations, LLC
This is an investigational multi-site outcomes registry intended to collect information about a patient's cancer care. Patients may enter the Registry at any time during the patient's current stage in the continuum of care. The registries main objectives will be to measure and evaluate the effects of patient care throughout the care continuum, resulting in the identification of the most effective treatment options. Objectives will encompass evaluations and analytics around safety, effectiveness, and improved efficiencies.

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Detailed Description

Q

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Tennessee
      • Nashville, Tennessee, United States, 37203
        • SCRI

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients 18yrs or older, that have been diagnosed with/ or are thought to have any form of cancer at any stage in the continuum of their care from screening through survivorship. Patient must have the ability to understand the nature of the trial and give written informed consent.

Description

Inclusion Criteria:

  • 18 or older
  • Patients that have been diagnosed with/ or are thought to have any form of cancer at any stage in the continuum of their care from screening through survivorship.
  • Patient must have the ability to understand the nature of the trial and give written informed consent

Exclusion Criteria:

  • There are no exclusion criteria for this Outcomes Registry

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
quality improvement
Time Frame: 10 yrs
10 yrs
Treatment patterns and utilization
Time Frame: 5 yrs
5 yrs

Secondary Outcome Measures

Outcome Measure
Time Frame
Humanistic and economic outcomes
Time Frame: 10 yrs
10 yrs

Other Outcome Measures

Outcome Measure
Time Frame
safety and effectiveness
Time Frame: 10 yrs
10 yrs

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

SCRI Development Innovations, LLC

Investigators

  • Principal Investigator: Richard Geer, MD, Sarah Cannon

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2014

Primary Completion (Estimated)

December 1, 2019

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

January 20, 2015

First Submitted That Met QC Criteria

February 4, 2015

First Posted (Estimated)

February 5, 2015

Study Record Updates

Last Update Posted (Estimated)

December 5, 2023

Last Update Submitted That Met QC Criteria

December 1, 2023

Last Verified

June 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SCRI HEOR_01

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Oncology

Clinical Trials on Patient registry

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe